Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.nature.com/articles/aps201734.pdf
Reference244 articles.
1. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, et al Non-small cell lung cancer. J Natl Compr Canc Netw 2010; 8: 740–801.
2. Cancer facts & figures. American Cancer Society 2016.
3. Jemal A, Center MM, Ward E . The convergence of lung cancer rates between blacks and whites under the age of 40, United States. Cancer Epidemiol Biomarkers Prev 2009; 18: 3349–52.
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.
5. Shepherd FA, Crowley J, Van Houtte P, Postmus PE, Carney D, Chansky K, et al The international association for the study of lung cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007; 2: 1067–77.
Cited by 193 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pulmonary inhalation for disease treatment: Basic research and clinical translations;Materials Today Bio;2024-04
2. Biosynthesis, characterization, magnetic hyperthermia, and in vitro toxicity evaluation of quercetin-loaded magnetoliposome lipid bilayer hybrid system on MCF-7 breast cancer;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-03
3. Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol;Journal of Controlled Release;2024-02
4. Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues;Journal of Drug Delivery Science and Technology;2024-02
5. The efficacy of bevacizumab combined with platinum-containing chemotherapy in the treatment of advanced non-small cell lung cancer in China: a systematic review and meta-analysis of randomized clinical trials;Frontiers in Pharmacology;2024-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3